Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Pregnenolone for the Treatment of Alcohol Use Disorder [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial at Yale University evaluating pregnenolone as a treatment for Alcohol Use Disorder. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregnenolone (pregnenolone)

Snippet

Sponsor: Yale University | Conditions: Alcohol Use Disorder | Phase 2 | Status: RECRUITING